Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen-Reference-Cited by-同舟云学术

Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen

Published:2012-07 Issue:1 Volume:746 Page:78-88
ISSN:1383-5718
Container-title:Mutation Research/Genetic Toxicology and Environmental Mutagenesis
language:en
Short-container-title:Mutation Research/Genetic Toxicology and Environmental Mutagenesis

Author:

Doppalapudi Rupa S.,Riccio Edward S.,Davis Zoe,Menda Sean,Wang Abraham,Du Nicholas,Green Carol,Kopelovich Levy,Rao Chinthalapally V.,Benbrook Doris M.,Kapetanovic Izet M.

Funder

National Cancer Institute

National Institutes of Health

Department of Health and Human Services

Publisher

Elsevier BV

Subject

Health, Toxicology and Mutagenesis,Genetics

Reference39 articles.

1. Rapid access to preventive intervention development program in the Division of Cancer Prevention of the U.S. National Cancer Institute: an overview;Kapetanovic;Cancer Epidemiol. Biomarkers Prev.,2009

2. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts;Wang;Proc. Natl. Acad. Sci. U.S.A.,2006

3. CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death;Wischhusen;Oncogene,2003